GlassScriptPhysician profile
Amit Merchant
NPI 1861623241
$4,416.28
in general payments reported to CMS, 2019-2025
22 companies · $452 in 2025
The $452 reported for 2025 was more than what a typical Pediatric Orthopaedic Surgery provider received nationally (typical 2025 total: $271).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,154 · 2020: $33.81 · 2021: $369 · 2022: $90.45 · 2023: $1,657 · 2024: $659 · 2025: $452.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,820 · Travel and Lodging: $949.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,819.60 |
| Travel and Lodging | $949.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seapearl East, INC | $1,364.43 | 2019-2024 | |
| Medical Device Business Services, INC. | $981.38 | 2023 | Expedium |
| Medtronic, INC. | $570.69 | 2023 | Mazor X System |
| Depuy Synthes Sales INC. | $360.48 | 2021-2025 | Expedium, Altalyne, Expedium Verse |
| Davol INC. | $283.40 | 2024-2025 | Channel Drain, Surgiphor |
| Arthrex, INC. | $224.95 | 2024 | |
| Miach Orthopaedics, INC. | $195.87 | 2025 | |
| Nuvasive, INC. | $100.41 | 2021-2023 | Reline |
| Pacira Pharmaceuticals Incorporated | $50.28 | 2021-2023 | Zilretta, Iovera, Exparel |
| Vertex Pharmaceuticals Incorporated | $43.41 | 2024-2025 | |
| Kci USA, INC. | $30.65 | 2021 | |
| Kerecis Limited | $30.43 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Pacira Therapeutics, INC. | $29.89 | 2020-2021 | |
| Think Surgical, INC. | $21.37 | 2021 | |
| Royal Biologics, INC. | $18.71 | 2020 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $18.34 | 2019 | |
| Dentsply Sirona INC | $17.41 | 2024 | Tph Spectra Universal Composite Restorative Low Viscosity |
| Averitas Pharma INC. | $16.81 | 2023 | Qutenza |
| Grt US Holding, INC. | $16.15 | 2022 | |
| Sanofi-Aventis U.S. LLC | $15.07 | 2021 | |
| Daiichi Sankyo INC. | $14.43 | 2021 | |
| Augmedics INC. | $11.72 | 2025 | Xvision |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amit Merchant listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.